Neuberger Berman Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $141M | Sell |
|
|||||
|
2021
Q1 | $123M | Sell |
|
|||||
|
2020
Q4 | $147M | Sell |
|
|||||
|
2020
Q3 | $131M | Buy |
|
|||||
|
2020
Q2 | $127M | Sell |
|
|||||
|
2020
Q1 | $115M | Sell |
|
|||||
|
2019
Q4 | $152M | Sell |
|
|||||
|
2019
Q3 | $152M | Buy |
|
|||||
|
2019
Q2 | $153M | Buy |
|
|||||
|
2019
Q1 | $136M | Buy |
|
|||||
|
2018
Q4 | $84.9M | Buy |
|
|||||
|
2018
Q3 | $81.4M | Buy |
|
|||||
|
2018
Q2 | $65.1M | Buy |
|
|||||
|
2018
Q1 | $42.3M | Buy |
|
|||||
|
2017
Q4 | $38.5M | Buy |
|
|||||
|
2017
Q3 | $38M | Sell |
|
|||||
|
2017
Q2 | $33.1M | Buy |
|
|||||
|
2017
Q1 | $750K | Buy |
|
|||||
|
2016
Q4 | $583K | Buy |
|
|||||
|
2016
Q3 | $341K | Sell |
|
|||||
|
2016
Q2 | $541K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $38.7M | Sell |
|
|||||
|
2014
Q1 | $38.8M | Sell |
|
|||||
|
2013
Q4 | $34.2M | Buy |
|
|||||
|
2013
Q3 | $25M | Sell |
|
|||||
|
2013
Q2 | $22.7M | Buy |
|